These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22697202)

  • 1. The use of MAOIs in primary care.
    Culpepper L
    J Clin Psychiatry; 2012 May; 73(5):e19. PubMed ID: 22697202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAOIs and depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of monoamine oxidase inhibitors in primary care.
    Culpepper L
    J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAOIs and transdermal delivery.
    Vandenberg CM
    J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAOIs: issues in treatment adherence and rates of treatment failure.
    Cohen LJ; Sclar DA
    J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting monoamine oxidase inhibitors.
    Krishnan KR
    J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA
    J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal selegiline.
    Patkar AA; Pae CU; Zarzar M
    Drugs Today (Barc); 2007 Jun; 43(6):361-77. PubMed ID: 17612708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors: a new generation.
    Robinson DS
    Psychopharmacol Bull; 2002; 36(3):124-38. PubMed ID: 12473970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of depression in the elderly.
    Williams GO
    Prim Care; 1989 Jun; 16(2):451-74. PubMed ID: 2664841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A history of the concept of atypical depression.
    Davidson JR
    J Clin Psychiatry; 2007; 68 Suppl 3():10-5. PubMed ID: 17348762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.
    Cohen LJ; Sclar DA
    J Clin Psychiatry; 2012; 73 Suppl 1():31-6. PubMed ID: 22951240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.